Recent research conducted by the University of Cologne and the Centre for Genomic Regulation (CRG) in Barcelona has led to a groundbreaking discovery in cancer research. Published in the journal eLIFE, the study overturns the long-standing belief that tumors grow predominantly at their outer edges.
Recent research conducted by NYU Langone Health and its Perlmutter Cancer Center has shed light on the remarkable adaptability of cancer cells in low-glucose environments. This study is pivotal in understanding how tumors evade the effects of chemotherapies, particularly those classified as
Researchers at Örebro University in Sweden have made a groundbreaking discovery in the field of inflammatory bowel disease (IBD). Their study has identified specific protein patterns in the blood that can predict the onset of IBD, including Crohn's disease and ulcerative colitis, years before
A promising new approach in battling Alzheimer's disease has emerged, involving an innovative nasal spray drug that targets a specific brain enzyme. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that inhibiting the enzyme
In a significant development for cardiovascular medicine, BridgeBio's Attruby (acoramidis) has received FDA approval for treating Transthyretin amyloid cardiomyopathy (ATTR-CM) in adults, marking a crucial milestone for a rare and severe heart condition that can lead to fatal outcomes if left
Schizophrenia is a severe mental health disorder that ranks as one of the leading causes of disability worldwide, significantly impacting memory, attention, and executive function. Despite the profound challenges it presents, there are currently no approved treatments for cognitive impairment
